Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes

被引:11
|
作者
Buss, Stephanie S. [1 ]
Padmanabhan, Jaya [1 ]
Saxena, Sadhvi [1 ,2 ]
Pascual-Leone, Alvaro [1 ,3 ]
Fried, Peter J. [1 ]
机构
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Berenson Allen Ctr Noninvas Brain Stimulat, Dept Neurol,Div Cognit Neurol, Boston, MA USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Univ Autonoma Barcelona, Inst Guttman, Barcelona, Spain
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; cognitive aging; dementia; diabetes mellitus; executive function; memory disorders; SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; INSULIN-RESISTANCE; SYNAPTIC PLASTICITY; AMYLOID DEPOSITION; COMPOSITE SCORE; STRUCTURAL MRI; BRAIN NETWORKS;
D O I
10.3233/JAD-180570
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Alzheimer's disease (AD) and type 2 diabetes (T2DM) are common causes of cognitive decline among older adults and share strong epidemiological links. Distinct patterns of cortical atrophy are observed in AD and T2DM, but robust comparisons between structure-function relationships across these two disease states are lacking. Objective: To compare how atrophy within distributed brain networks is related to cognition across the spectrum of cognitive aging. Methods: The relationship between structural MRI changes and cognition was studied in 22 mild-to-moderate AD, 28 T2DM, and 27 healthy participants. Cortical thickness measurements were obtained from networks of interest (NOIs) matching the limbic, default, and frontoparietal resting-state networks. Composite cognitive scores capturing domains of global cognition, memory, and executive function were created. Associations between cognitive scores and the NOIs were assessed using linear regression, with age as a covariate. Within-network General Linear Model (GLM) analysis was run in Freesurfer 6.0 to visualize differences in patterns of cortical atrophy related to cognitive function in each group. A secondary analysis examined hemispheric differences in each group. Results: Across all groups, cortical atrophy within the limbic NOI was significantly correlated with Global Cognition (p = 0.009) and Memory Composite (p = 0.002). Within-network GLM analysis and hemispheric analysis revealed qualitatively different patterns of atrophy contributing to cognitive dysfunction between AD and T2DM. Conclusion: Brain network atrophy is related to cognitive function across AD, T2DM, and healthy participants. Differences in cortical atrophy patterns were seen between AD and T2DM, highlighting neuropathological differences.
引用
收藏
页码:1301 / 1312
页数:12
相关论文
共 50 条
  • [1] Connecting Type 2 diabetes to Alzheimer's disease
    De Felice, Fernanda G.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 1297 - 1299
  • [2] Epigenomic Approach in Understanding Alzheimer's Disease and Type 2 Diabetes Mellitus
    Shaik, Munvar M.
    Gan, Siew H.
    Kamal, Mohammad A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (02) : 283 - 289
  • [3] Apathy and cortical atrophy in Alzheimer's disease
    Tunnard, C.
    Whitehead, D.
    Hurt, C.
    Wahlund, L. O.
    Mecocci, P.
    Tsolaki, M.
    Vellas, B.
    Spenger, C.
    Kloszewska, I.
    Soininen, H.
    Lovestone, S.
    Simmons, A.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 26 (07) : 741 - 748
  • [4] Type 2 diabetes and Alzheimer's disease - are there common microbial roots?
    Fekete, Cintia
    Schandl, Laszlo
    Tomasics, Gyula
    Egey, Andras
    Kis, Janos Tibor
    Winkler, Gabor
    ORVOSI HETILAP, 2024, 165 (39) : 1522 - 1528
  • [5] Adiposity, Type 2 Diabetes, and Alzheimer's Disease
    Luchsinger, Jose A.
    Gustafson, Deborah R.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (04) : 693 - 704
  • [6] Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease
    Dhiman, Kunal
    Gupta, Veer Bala
    Villemagne, Victor L.
    Eratne, Dhamidhu
    Graham, Petra L.
    Fowler, Christopher
    Bourgeat, Pierrick
    Li, Qiao-Xin
    Collins, Steven
    Bush, Ashley, I
    Rowe, Christopher C.
    Masters, Colin L.
    Ames, David
    Hone, Eugene
    Blennow, Kaj
    Zetterberg, Henrik
    Martins, Ralph N.
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2020, 12 (01)
  • [7] Hippocampal atrophy, asymmetry, and cognition in type 2 diabetes mellitus
    Milne, Nicole T.
    Bucks, Romola S.
    Davis, Wendy A.
    Davis, Timothy M. E.
    Pierson, Ronald
    Starkstein, Sergio E.
    Bruce, David G.
    BRAIN AND BEHAVIOR, 2018, 8 (01):
  • [8] The Role of Steroidomics in the Diagnosis of Alzheimer's Disease and Type 2 Diabetes Mellitus
    Vankova, Marketa
    Velikova, Marta
    Vejrazkova, Daniela
    Vcelak, Josef
    Lukasova, Petra
    Rusina, Robert
    Vankova, Hana
    Jarolimova, Eva
    Kancheva, Radmila
    Bulant, Josef
    Horackova, Lenka
    Bendlova, Bela
    Hill, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [9] Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease
    Weintraub, Daniel
    Dietz, Nicole
    Duda, John E.
    Wolk, David A.
    Doshi, Jimit
    Xie, Sharon X.
    Davatzikos, Christos
    Clark, Christopher M.
    Siderowf, Andrew
    BRAIN, 2012, 135 : 170 - 180
  • [10] Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease
    Ong, Marissa
    Foo, Heidi
    Chander, Russell Jude
    Wen, Ming-Ching
    Au, Wing Lok
    Sitoh, Yih Yian
    Tan, Louis
    Kandiah, Nagaendran
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 377 : 122 - 126